Structure (Oxaliplatin 01)
Chemical structure of oxaliplatin, depicting the platinum atom coordinated with a cyclohexane diamine ligand and oxalate groups.*
Oxaliplatin Injection, Solution
Product Images NDC 60505-6287
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oxaliplatin (NDC 60505-6287). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Oxaliplatin 02)
A Kaplan-Meier survival curve illustrating disease-free survival (DFS) probability over months for two treatment arms: FOLFOX4 and LV5FU2. The chart includes hazard ratio, confidence interval, p-value, number of events, and number of patients at risk across time points up to 72 months.*
Figure 2 (Oxaliplatin 03)
A survival probability curve chart showing Disease-Free Survival (DFS) probability over time in months. The chart compares two treatment arms labeled FOLFOX4 - DUKES C and LV5FU2 - DUKES C with respective survival curves. It includes a hazard ratio of 0.78 with a 95% confidence interval, and a logrank test p-value of 0.005.*
Figure 3 (Oxaliplatin 04)
A survival curve chart showing percentage of patients surviving over 24 months. It compares median survival among three groups: Oxaliplatin Injection USP plus 5-FU/LV, Oxaliplatin Injection USP plus irinotecan, and Irinotecan plus 5-FU/LV, with median survival times of 19.4, 17.6, and 14.6 months respectively. The chart includes a p-value indicating statistical significance of the comparison.*
50 mg/10 mL Container (Oxaliplatin 05)
Label for Oxaliplatin Injection, USP 50 mg/10 mL (5 mg/mL) solution for intravenous use. It is a 10 mL single-dose vial of sterile aqueous solution without preservatives. The label includes warnings about not mixing with sodium chloride solutions and storage instructions. The product is labeled by Apotex Corp. and manufactured by QILU Pharmaceutical (Hainan) Co., Ltd.*
50 mg/10 mL Carton (Oxaliplatin 06)
Label for Oxaliplatin Injection, USP, 50 mg/10 mL (5 mg/mL) intravenous solution, single-dose vial by Apotex Corp. The label includes dosing, storage instructions, cautions about cytotoxicity, and warnings against mixing with sodium chloride solutions. The packaging features the Novaplus brand and a barcode with associated NDC 60505-6287-2. Manufactured by QILU Pharmaceutical (Hainan) Co., Ltd., China.*
100 mg/20 mL Container (Oxaliplatin 07)
Oxaliplatin Injection, USP 100 mg/20 mL (5 mg/mL) single-dose vial label for intravenous use. The sterile aqueous solution is preservative free. Label shows manufacturer information including QILU Pharmaceutical (Hainan) Co., Ltd. and Apotex Corp., with storage and handling cautions, barcode, and placeholders for GTIN, lot, and expiration date.*
100 mg/20 mL Container (Oxaliplatin 08)
Packaging label for Oxaliplatin Injection, USP, 100 mg/20 mL (5 mg/mL) intravenous solution by Apotex Corp. The label features dosage strength prominently in yellow and orange blocks, states it is a single-dose vial, preservative free, and contains a cytotoxic agent. Manufacturer is QILU Pharmaceutical (Hainan) Co., Ltd, China, with distributor Apotex Corp., USA. Includes storage and handling instructions and a barcode.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
